Researchers Study Disease During Spaceflight

ASU Biodesign Institute researchers are using the unique conditions of spaceflight to examine how cells remain healthy or succumb to disease, particularly in the face of stress or damage. Their experiment will be launched into low earth orbit on April 5 aboard the space shuttle Discovery on mission STS-131. The team hopes to provide fundamental new insight into the infectious disease process, and further undestanding of other progressive diseases, including immune disorders and cancer. The Results of the current study will also be used to help mitigate infectious disease risks to the crew, who are particularly vulnerable to infection, due to reduced immune function during spaceflight missions. read more

Read the whole article on

More from